None listed
Conditions
Interventions
Intervention1: Structured Exercise Regimen: EXPERIMENTAL GROUP (STRUCTURED EXERCISE PROGRAM + STANDARD CARE)
TOTAL DURATION: 45-60 Mins for 12 weeks (3 times per week to be done)
Participants in the
and exhale through the mouth (with the count of seven).
Progression: Exercise duration will be gradually increased every two weeks, ensuring safety and tolerability. Adherence will be documented throu
Sponsors
GVNSLS Vaishnavi
Eligibility
Inclusion criteria
Inclusion criteria: Women aged 18 - 45 years. Should be able to understand and read English. Menstrual pain greater than 4 on a numeric rating scale (NPRS). Not currently engaged in structured exercise programs. Stable metabolic status (no recent drastic weight changes in the past 3 months). Willing to commit to a 12-week structured exercise program. Ability to provide informed consent.
Exclusion criteria
Exclusion criteria: Pregnant and Lactating women. Any other medical or gynaecological conditions. Participation in any other physical activity program or sports program. Any physical limitations preventing exercise participation (e.g., musculoskeletal disorders). An active genitourinary infection in the previous 4 weeks. BMI greater than 35 Any acute inflammations. Participants completing less than 75 percent of sessions (i.e., less than 27 out of 36) will be excluded from final analysis. On medications that directly influence insulin resistance or lipid metabolism (e.g., metformin). Currently engaged in structured exercise programs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Biochemical Parameters: Serum CCL5 and Lipid profile parameters will be measured to evaluate inflammatory and metabolic changes associated with primary dysmenorrhea. Timepoint: Serum CCL5 (pg/mL) measured before and after 12 weeks. Lipid profile (TC, TG, HDL, LDL) measured before and after 12 weeks using Beckman Coulter DXC700. Anthropometric parameters (BMI, weight) documented before & after intervention, 12 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain: Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS). Questionnaires: Quality of life will be evaluated using the Short Form SF-36 Health Survey & MEDI-Q questionnaire, both of which are validated instruments for capturing physical, emotional, & social impacts of menstrual disorders.Timepoint: - Lipid profile (TC, TG, HDL, LDL) measured after 12 weeks using Beckman Coulter DXC700. - Anthropometric parameters (BMI, weight) documented before & after intervention, 12 weeks. | — |
Countries
India
Contacts
Public ContactDr V M Vinodhini
SRM Medical College Hospital and Research Centre
Outcome results
None listed